106 related articles for article (PubMed ID: 10718483)
21. Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.
Schlemmer BO; Sorensen BS; Overgaard J; Olsen KE; Gjerdrum LM; Nexo E
Scand J Clin Lab Invest; 2004; 64(5):511-22. PubMed ID: 15276916
[TBL] [Abstract][Full Text] [Related]
22. p185HER2 overexpression in human breast cancer using molecular and immunohistochemical methods.
Johnson RC; Ricci A; Cartun RW; Ackroyd R; Tsongalis GJ
Cancer Invest; 2000; 18(4):336-42. PubMed ID: 10808369
[TBL] [Abstract][Full Text] [Related]
23. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
24. An alternative and reliable real-time quantitative PCR method to determine HER2/neu amplification in breast cancer.
Egervari K; Toth J; Nemes Z; Szollosi Z
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):247-54. PubMed ID: 19098680
[TBL] [Abstract][Full Text] [Related]
25. A differential PCR assay for the detection of c-erbB 2 amplification used in a prospective study of breast cancer.
Jennings BA; Hadfield JE; Worsley SD; Girling A; Willis G
Mol Pathol; 1997 Oct; 50(5):254-6. PubMed ID: 9497915
[TBL] [Abstract][Full Text] [Related]
26. Competitive reverse transcriptase-PCR: an improved method for determination of c-erbB-2 gene expression.
Schneeberger C; Eder S; Speiser P; Zeillinger R
Anticancer Res; 1996; 16(2):849-52. PubMed ID: 8687140
[TBL] [Abstract][Full Text] [Related]
27. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
28. Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use.
Bánkfalvi A; Simon R; Brandt B; Bürger H; Vollmer I; Dockhorn-Dworniczak B; Lellé RJ; Boecker W
Histopathology; 2000 Nov; 37(5):411-9. PubMed ID: 11119122
[TBL] [Abstract][Full Text] [Related]
29. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure c-erbB-2 oncogene amplification.
Gelmini S; Orlando C; Sestini R; Vona G; Pinzani P; Ruocco L; Pazzagli M
Clin Chem; 1997 May; 43(5):752-8. PubMed ID: 9166227
[TBL] [Abstract][Full Text] [Related]
30. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
[TBL] [Abstract][Full Text] [Related]
31. Competitive-differential polymerase chain reaction for gene dosage estimation of erbB-1 (egfr), erbB-2, and erbB-3 oncogenes.
Roetger A; Brandt B; Barnekow A
DNA Cell Biol; 1997 Apr; 16(4):443-8. PubMed ID: 9150431
[TBL] [Abstract][Full Text] [Related]
32. Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.
López-Guerrero JA; Navarro S; Noguera R; Almenar S; Pellin A; Vázquez C; Llombart-Bosch A
Arkh Patol; 2003; 65(1):50-5. PubMed ID: 12669615
[TBL] [Abstract][Full Text] [Related]
33. Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients.
Otsuji K; Sasaki T; Tanaka A; Kunita A; Ikemura M; Matsusaka K; Tada K; Fukayama M; Seto Y
Breast Cancer Res Treat; 2017 Feb; 162(1):11-18. PubMed ID: 28039535
[TBL] [Abstract][Full Text] [Related]
34. Analysis of gene amplification in archival tissue by differential polymerase chain reaction.
Neubauer A; Neubauer B; He M; Effert P; Iglehart D; Frye RA; Liu E
Oncogene; 1992 May; 7(5):1019-25. PubMed ID: 1349162
[TBL] [Abstract][Full Text] [Related]
35. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction.
Crabbe DC; Peters J; Seeger RC
Diagn Mol Pathol; 1992 Dec; 1(4):229-34. PubMed ID: 1342970
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of gene-amplification by PCR in archival paraffin-embedded breast cancer tissue.
Lönn U; Lönn S; Nilsson B; Silfverswärd C; Stenkvist B
Breast Cancer Res Treat; 1994; 30(2):147-52. PubMed ID: 7949213
[TBL] [Abstract][Full Text] [Related]
37. Detection of loss of heterozygosity in tumor DNA samples by PCR.
Merlo GR; Cropp CS; Callahan R; Takahashi T
Biotechniques; 1991 Aug; 11(2):166-8, 170-1. PubMed ID: 1931011
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of c-erbB-2 amplification in breast carcinoma by differential polymerase chain reaction.
Gramlich TL; Cohen C; Fritsch C; DeRose PB; Gansler T
Am J Clin Pathol; 1994 Apr; 101(4):493-9. PubMed ID: 7909190
[TBL] [Abstract][Full Text] [Related]
39. Amplification in tumors and benign tissue of breast cancer patients.
Yazici H; Müslümanoğlu M; Güzey D; Yasasever V; Ozbek U; Dalay N
Cancer Lett; 1996 Oct; 107(2):235-9. PubMed ID: 8947519
[TBL] [Abstract][Full Text] [Related]
40. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer.
Bièche I; Olivi M; Champème MH; Vidaud D; Lidereau R; Vidaud M
Int J Cancer; 1998 Nov; 78(5):661-6. PubMed ID: 9808539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
